table of content
1 Study Coverage
1.1 Bile Duct Cancer Drug Product Introduction
1.2 Market by Type
1.2.1 Global Bile Duct Cancer Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cabozantinib S-malate
1.2.3 Elpamotide
1.2.4 Exatecan Mesylate
1.2.5 LY-2801653
1.2.6 NUC-1031
1.2.7 Others
1.3 Market by Application
1.3.1 Global Bile Duct Cancer Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bile Duct Cancer Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Bile Duct Cancer Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Bile Duct Cancer Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Bile Duct Cancer Drug Sales by Region
2.4.1 Global Bile Duct Cancer Drug Sales by Region (2017-2022)
2.4.2 Global Sales Bile Duct Cancer Drug by Region (2023-2028)
2.5 Global Bile Duct Cancer Drug Revenue by Region
2.5.1 Global Bile Duct Cancer Drug Revenue by Region (2017-2022)
2.5.2 Global Bile Duct Cancer Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Bile Duct Cancer Drug Sales by Manufacturers
3.1.1 Global Top Bile Duct Cancer Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Bile Duct Cancer Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bile Duct Cancer Drug in 2021
3.2 Global Bile Duct Cancer Drug Revenue by Manufacturers
3.2.1 Global Bile Duct Cancer Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Bile Duct Cancer Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Bile Duct Cancer Drug Revenue in 2021
3.3 Global Bile Duct Cancer Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Bile Duct Cancer Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Bile Duct Cancer Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bile Duct Cancer Drug Sales by Type
4.1.1 Global Bile Duct Cancer Drug Historical Sales by Type (2017-2022)
4.1.2 Global Bile Duct Cancer Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Bile Duct Cancer Drug Sales Market Share by Type (2017-2028)
4.2 Global Bile Duct Cancer Drug Revenue by Type
4.2.1 Global Bile Duct Cancer Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Bile Duct Cancer Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Bile Duct Cancer Drug Revenue Market Share by Type (2017-2028)
4.3 Global Bile Duct Cancer Drug Price by Type
4.3.1 Global Bile Duct Cancer Drug Price by Type (2017-2022)
4.3.2 Global Bile Duct Cancer Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Bile Duct Cancer Drug Sales by Application
5.1.1 Global Bile Duct Cancer Drug Historical Sales by Application (2017-2022)
5.1.2 Global Bile Duct Cancer Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Bile Duct Cancer Drug Sales Market Share by Application (2017-2028)
5.2 Global Bile Duct Cancer Drug Revenue by Application
5.2.1 Global Bile Duct Cancer Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Bile Duct Cancer Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Bile Duct Cancer Drug Revenue Market Share by Application (2017-2028)
5.3 Global Bile Duct Cancer Drug Price by Application
5.3.1 Global Bile Duct Cancer Drug Price by Application (2017-2022)
5.3.2 Global Bile Duct Cancer Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Bile Duct Cancer Drug Market Size by Type
6.1.1 North America Bile Duct Cancer Drug Sales by Type (2017-2028)
6.1.2 North America Bile Duct Cancer Drug Revenue by Type (2017-2028)
6.2 North America Bile Duct Cancer Drug Market Size by Application
6.2.1 North America Bile Duct Cancer Drug Sales by Application (2017-2028)
6.2.2 North America Bile Duct Cancer Drug Revenue by Application (2017-2028)
6.3 North America Bile Duct Cancer Drug Market Size by Country
6.3.1 North America Bile Duct Cancer Drug Sales by Country (2017-2028)
6.3.2 North America Bile Duct Cancer Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Bile Duct Cancer Drug Market Size by Type
7.1.1 Europe Bile Duct Cancer Drug Sales by Type (2017-2028)
7.1.2 Europe Bile Duct Cancer Drug Revenue by Type (2017-2028)
7.2 Europe Bile Duct Cancer Drug Market Size by Application
7.2.1 Europe Bile Duct Cancer Drug Sales by Application (2017-2028)
7.2.2 Europe Bile Duct Cancer Drug Revenue by Application (2017-2028)
7.3 Europe Bile Duct Cancer Drug Market Size by Country
7.3.1 Europe Bile Duct Cancer Drug Sales by Country (2017-2028)
7.3.2 Europe Bile Duct Cancer Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Bile Duct Cancer Drug Market Size by Type
8.1.1 Asia Pacific Bile Duct Cancer Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Bile Duct Cancer Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Bile Duct Cancer Drug Market Size by Application
8.2.1 Asia Pacific Bile Duct Cancer Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Bile Duct Cancer Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Bile Duct Cancer Drug Market Size by Region
8.3.1 Asia Pacific Bile Duct Cancer Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Bile Duct Cancer Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Bile Duct Cancer Drug Market Size by Type
9.1.1 Latin America Bile Duct Cancer Drug Sales by Type (2017-2028)
9.1.2 Latin America Bile Duct Cancer Drug Revenue by Type (2017-2028)
9.2 Latin America Bile Duct Cancer Drug Market Size by Application
9.2.1 Latin America Bile Duct Cancer Drug Sales by Application (2017-2028)
9.2.2 Latin America Bile Duct Cancer Drug Revenue by Application (2017-2028)
9.3 Latin America Bile Duct Cancer Drug Market Size by Country
9.3.1 Latin America Bile Duct Cancer Drug Sales by Country (2017-2028)
9.3.2 Latin America Bile Duct Cancer Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Bile Duct Cancer Drug Market Size by Type
10.1.1 Middle East and Africa Bile Duct Cancer Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Bile Duct Cancer Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Bile Duct Cancer Drug Market Size by Application
10.2.1 Middle East and Africa Bile Duct Cancer Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Bile Duct Cancer Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Bile Duct Cancer Drug Market Size by Country
10.3.1 Middle East and Africa Bile Duct Cancer Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Bile Duct Cancer Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Ariad Pharmaceuticals, Inc.
11.1.1 Ariad Pharmaceuticals, Inc. Corporation Information
11.1.2 Ariad Pharmaceuticals, Inc. Overview
11.1.3 Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Ariad Pharmaceuticals, Inc. Recent Developments
11.2 ArQule, Inc.
11.2.1 ArQule, Inc. Corporation Information
11.2.2 ArQule, Inc. Overview
11.2.3 ArQule, Inc. Bile Duct Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 ArQule, Inc. Bile Duct Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 ArQule, Inc. Recent Developments
11.3 Array BioPharma Inc.
11.3.1 Array BioPharma Inc. Corporation Information
11.3.2 Array BioPharma Inc. Overview
11.3.3 Array BioPharma Inc. Bile Duct Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Array BioPharma Inc. Bile Duct Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Array BioPharma Inc. Recent Developments
11.4 Arrien Pharmaceuticals, LLC
11.4.1 Arrien Pharmaceuticals, LLC Corporation Information
11.4.2 Arrien Pharmaceuticals, LLC Overview
11.4.3 Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Arrien Pharmaceuticals, LLC Recent Developments
11.5 Aslan Pharmaceuticals Pte. Ltd.
11.5.1 Aslan Pharmaceuticals Pte. Ltd. Corporation Information
11.5.2 Aslan Pharmaceuticals Pte. Ltd. Overview
11.5.3 Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Aslan Pharmaceuticals Pte. Ltd. Recent Developments
11.6 Bavarian Nordic A/S
11.6.1 Bavarian Nordic A/S Corporation Information
11.6.2 Bavarian Nordic A/S Overview
11.6.3 Bavarian Nordic A/S Bile Duct Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bavarian Nordic A/S Bile Duct Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bavarian Nordic A/S Recent Developments
11.7 Bayer AG
11.7.1 Bayer AG Corporation Information
11.7.2 Bayer AG Overview
11.7.3 Bayer AG Bile Duct Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bayer AG Bile Duct Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bayer AG Recent Developments
11.8 Blueprint Medicines Corporation
11.8.1 Blueprint Medicines Corporation Corporation Information
11.8.2 Blueprint Medicines Corporation Overview
11.8.3 Blueprint Medicines Corporation Bile Duct Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Blueprint Medicines Corporation Bile Duct Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Blueprint Medicines Corporation Recent Developments
11.9 Boehringer Ingelheim GmbH
11.9.1 Boehringer Ingelheim GmbH Corporation Information
11.9.2 Boehringer Ingelheim GmbH Overview
11.9.3 Boehringer Ingelheim GmbH Bile Duct Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Boehringer Ingelheim GmbH Bile Duct Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Boehringer Ingelheim GmbH Recent Developments
11.10 Boston Biomedical, Inc.
11.10.1 Boston Biomedical, Inc. Corporation Information
11.10.2 Boston Biomedical, Inc. Overview
11.10.3 Boston Biomedical, Inc. Bile Duct Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Boston Biomedical, Inc. Bile Duct Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Boston Biomedical, Inc. Recent Developments
11.11 Bristol-Myers Squibb Company
11.11.1 Bristol-Myers Squibb Company Corporation Information
11.11.2 Bristol-Myers Squibb Company Overview
11.11.3 Bristol-Myers Squibb Company Bile Duct Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Bristol-Myers Squibb Company Bile Duct Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Bristol-Myers Squibb Company Recent Developments
11.12 Celgene Corporation
11.12.1 Celgene Corporation Corporation Information
11.12.2 Celgene Corporation Overview
11.12.3 Celgene Corporation Bile Duct Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Celgene Corporation Bile Duct Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Celgene Corporation Recent Developments
11.13 CellAct Pharma GmbH
11.13.1 CellAct Pharma GmbH Corporation Information
11.13.2 CellAct Pharma GmbH Overview
11.13.3 CellAct Pharma GmbH Bile Duct Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 CellAct Pharma GmbH Bile Duct Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 CellAct Pharma GmbH Recent Developments
11.14 Cellceutix Corporation
11.14.1 Cellceutix Corporation Corporation Information
11.14.2 Cellceutix Corporation Overview
11.14.3 Cellceutix Corporation Bile Duct Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Cellceutix Corporation Bile Duct Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Cellceutix Corporation Recent Developments
11.15 Cellular Biomedicine Group, Inc.
11.15.1 Cellular Biomedicine Group, Inc. Corporation Information
11.15.2 Cellular Biomedicine Group, Inc. Overview
11.15.3 Cellular Biomedicine Group, Inc. Bile Duct Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Cellular Biomedicine Group, Inc. Bile Duct Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Cellular Biomedicine Group, Inc. Recent Developments
11.16 Concordia Healthcare Corp.
11.16.1 Concordia Healthcare Corp. Corporation Information
11.16.2 Concordia Healthcare Corp. Overview
11.16.3 Concordia Healthcare Corp. Bile Duct Cancer Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Concordia Healthcare Corp. Bile Duct Cancer Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Concordia Healthcare Corp. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bile Duct Cancer Drug Industry Chain Analysis
12.2 Bile Duct Cancer Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bile Duct Cancer Drug Production Mode & Process
12.4 Bile Duct Cancer Drug Sales and Marketing
12.4.1 Bile Duct Cancer Drug Sales Channels
12.4.2 Bile Duct Cancer Drug Distributors
12.5 Bile Duct Cancer Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Bile Duct Cancer Drug Industry Trends
13.2 Bile Duct Cancer Drug Market Drivers
13.3 Bile Duct Cancer Drug Market Challenges
13.4 Bile Duct Cancer Drug Market Restraints
14 Key Findings in The Global Bile Duct Cancer Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
